Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Head and Neck Neoplasms 7Squamous Cell Carcinoma of Head and Neck 5Oropharyngeal Neoplasms 3Tongue Neoplasms 1Thyroid Neoplasms 1Radiation Injuries 1Pain, Postoperative 1Pain 1Mucositis 1Mouth Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Medullary 1Carcinoma 1

Interventions

vandetanib 12cabozantinib 8selpercatinib 5Sorafenib 5Everolimus 5Magnetic Resonance Spectroscopy 3Capecitabine 3sargramostim 2pralsetinib 2lutetium Lu 177 dotatate 2lenvatinib 2Trastuzumab 2Temozolomide 2Sunitinib 2Specimen Handling 2Octreotide 2High-Energy Shock Waves 2Gefitinib 2Doxorubicin 2yeast-CEA vaccine 1veliparib 1vatalanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1temsirolimus 1tanespimycin 1sacubitril and valsartan sodium hydrate drug combination 1rovalpituzumab tesirine 1ponatinib 1pentetreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Medullary × Neck Dissection × Clear all
NCT07612293 2026-05-28

STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection

Jonsson Comprehensive Cancer Center

Phase NA Not yet recruiting
100 enrolled

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡